Pinealon

✓Key benefits

📈What to expect

Based on community reports and published research. Individual results vary significantly.

💊Dosing protocols

Dosing information is sourced from published research and community protocols. This is not a recommendation. Consult a healthcare professional.

Overview

Pinealon belongs to a class of short peptide bioregulators developed by Professor Vladimir Khavinson at the Saint Petersburg Institute of Bioregulation and Gerontology. These peptides are theorised to regulate gene expression in specific tissues by interacting directly with DNA. Pinealon (Glu-Asp-Arg) is designed for the pineal gland, the structure responsible for melatonin production and circadian rhythm regulation. In cell culture and animal studies, pinealon has been shown to increase melatonin synthesis, provide neuroprotective effects against oxidative stress, and improve cognitive function in aging models. It is available orally in capsule form and does not require injection.

⚙️How it works

Khavinson's bioregulation theory proposes that short peptides (2-4 amino acids) can penetrate the nucleus and interact with specific DNA sequences, influencing gene expression in target tissues. Pinealon is reported to upregulate genes involved in melatonin synthesis (AANAT, ASMT) in pinealocytes and enhance antioxidant enzyme expression in neural tissue. In vitro studies have demonstrated neuroprotective effects: pinealon reduced cortical neuron death by 35-40% under oxidative stress conditions. It may also modulate serotonin metabolism, the precursor pathway to melatonin production.

⚡Side effects

📅Research history

Khavinson bioregulators: the Russian peptide tradition

Professor Vladimir Khavinson developed over 20 short peptide bioregulators at the Saint Petersburg Institute of Bioregulation and Gerontology, each targeting specific organs: Epithalamin/Epithalon (pineal), Thymalin (thymus), Cortexin (brain), and many others. These peptides are prescribed clinically in Russia and several former Soviet states. Pinealon is the oral-available version of Epithalamin's function. While Western peer-reviewed data is limited, the Khavinson group has published over 200 papers and holds patents in multiple countries. The bioregulator approach is distinct from Western pharmacology and should be evaluated accordingly.

Pinealon for sleep optimisation

Unlike supplemental melatonin (which provides exogenous hormone), pinealon aims to normalise the pineal gland's own melatonin production. This distinction matters because exogenous melatonin can suppress endogenous production over time, while a bioregulator approach theoretically restores the gland's function. Users typically report improved sleep onset, deeper sleep architecture, and more consistent circadian timing. The short cycling protocol (10-20 days) is designed to 'reset' pineal function rather than provide ongoing supplementation.

References

1. [1]Khavinson VK, et al. 'Pinealon increases cell viability by suppression of free radical levels and activating proliferative processes.' Rejuvenation Research, 2011.
2. [2]Khavinson VK, Malinin VV. 'Gerontological aspects of genome peptide regulation.' Karger, 2005.

Frequently asked questions

Related peptides